Open Lending (NASDAQ:LPRO – Get Free Report) is projected to release its Q4 2025 results before the market opens on Monday, March 30th. Analysts expect Open Lending to post earnings of $0.02 per share for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on […]

IO Biotech (NASDAQ:IOBT – Get Free Report) will likely be issuing its Q4 2025 results before the market opens on Monday, March 30th. Analysts expect IO Biotech to post earnings of ($0.16) per share for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on […]

ASP Isotopes (NASDAQ:ASPI – Get Free Report) will likely be releasing its Q4 2025 results after the market closes on Monday, March 30th. Analysts expect ASP Isotopes to post earnings of ($0.1367) per share and revenue of $2.0310 million for the quarter. Investors may visit the the company’s upcoming Q4 2025 earning results page for […]

RenovoRx (NASDAQ:RNXT – Get Free Report) will likely be posting its Q4 2025 results after the market closes on Monday, March 30th. Analysts expect RenovoRx to post earnings of ($0.08) per share and revenue of $0.42 million for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the […]

Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) is projected to issue its Q4 2025 results before the market opens on Monday, March 30th. Analysts expect the company to announce earnings of ($0.0543) per share for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on […]

Quince Therapeutics (NASDAQ:QNCX – Get Free Report) is expected to be issuing its Q4 2025 results before the market opens on Monday, March 23rd. Analysts expect Quince Therapeutics to post earnings of ($0.2250) per share for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details […]

Adagene (NASDAQ:ADAG – Get Free Report) is expected to be announcing its Q4 2025 results before the market opens on Monday, March 23rd. Analysts expect the company to announce earnings of ($0.28) per share for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details […]

BioLineRx (NASDAQ:BLRX – Get Free Report) is expected to announce its Q4 2025 results before the market opens on Monday, March 23rd. Analysts expect the company to announce earnings of ($0.50) per share and revenue of $0.4920 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for […]